T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THS
226
DELISTED
Treehouse Foods
THS
| $480M | 0.1% |
5,537,967
+1,014,614
| +22% | +$81.1M |
|
227
Global Payments
GPN
$24.8B
| $480M | 0.1% |
7,352,813
+56,960
| +0.8% | +$3.38M |
|
228
Centene
CNC
$32.5B
| $479M | 0.1% |
15,555,312
+4,211,316
| +37% | +$126M |
|
229
TE Connectivity
TEL
$62.4B
| $479M | 0.1% |
7,729,558
-438,387
| -5% | -$25.5M |
|
230
Choice Hotels
CHH
$4.69B
| $476M | 0.1% |
8,805,948
-267,693
| -3% | -$12.9M |
|
231
Universal Health Services
UHS
$10.1B
| $474M | 0.1% |
3,799,834
+381,683
| +11% | +$42.9M |
|
232
Xcel Energy
XEL
$49.1B
| $471M | 0.1% |
11,251,001
-11,068,196
| -50% | -$431M |
|
233
Cummins
CMI
$87.2B
| $468M | 0.1% |
4,256,611
+1,895,674
| +80% | +$183M |
|
234
Fidelity National Information Services
FIS
$22.5B
| $459M | 0.1% |
7,254,845
+501,990
| +7% | +$30.1M |
|
235
CME Group
CME
$95.5B
| $459M | 0.1% |
4,775,282
+2,725,813
| +133% | +$248M |
|
|
TFCFA
236
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $458M | 0.1% |
16,431,212
-9,025,402
| -35% | -$242M |
|
237
Kohl's
KSS
$2.22B
| $454M | 0.1% |
9,735,008
-4,816,625
| -33% | -$226M |
|
238
JD.com
JD
$39.5B
| $450M | 0.1% |
16,993,182
-302,324
| -2% | -$7.94M |
|
239
AbbVie
ABBV
$441B
| $448M | 0.1% |
7,836,836
-1,069,896
| -12% | -$59.6M |
|
240
Vail Resorts
MTN
$5.22B
| $442M | 0.09% |
3,302,950
-1,580
| -0% | -$198K |
|
241
Emerson Electric
EMR
$90.9B
| $440M | 0.09% |
8,098,575
-1,349,556
| -14% | -$65.1M |
|
242
Conagra Brands
CAG
$7.38B
| $440M | 0.09% |
12,677,338
+2,844,835
| +29% | +$92.3M |
|
|
K
243
DELISTED
Kellanova
K
| $440M | 0.09% |
6,118,342
-1,168,722
| -16% | -$80.7M |
|
244
Cardinal Health
CAH
$53.5B
| $436M | 0.09% |
5,315,927
+177,997
| +3% | +$14.5M |
|
245
Ingredion
INGR
$6.65B
| $435M | 0.09% |
4,072,394
-665,334
| -14% | -$66.3M |
|
246
Equity Residential
EQR
$24.7B
| $433M | 0.09% |
5,773,947
+560,553
| +11% | +$41.9M |
|
247
Amgen
AMGN
$225B
| $423M | 0.09% |
2,824,238
-317,947
| -10% | -$47.2M |
|
248
Prologis
PLD
$134B
| $423M | 0.09% |
9,580,081
+926,661
| +11% | +$37.2M |
|
249
Analog Devices
ADI
$187B
| $419M | 0.09% |
7,080,954
+1,508,937
| +27% | +$80.6M |
|
250
General Motors
GM
$75.9B
| $419M | 0.09% |
13,325,079
-72,435
| -0.5% | -$2.18M |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.